Revisiting the association between candidal infection and carcinoma, particularly oral squamous cell carcinoma

References

• Parkin DM. The global health burden infection-associated cancers in year 2002. Int J Cancer. 2006; 118: 3030–44.
   PubMed Web of Science ®Google Scholar
• de Martel C, Franceschi S. Infections and cancer: established associations and new hypotheses. Crit Rev Oncol Hematol. 2009; 70: 183–94.
   PubMed Web of Science ®Google Scholar
• Pagano JS, Blaser M, Buendia M-A, Damania B, Khalili K, Raab-Traub N, et al.. Infectious agents and cancer: criteria for a causal relation. Semin Cancer Biol. 2004; 14: 453–71.
   PubMed Web of Science ®Google Scholar
• Ryerson AB, Peters ES, Coughlin SS, Chen VW, Gillison ML, Reichman ME, et al.. Burden of potentially human papilloma virus-associated cancers of the oropharynx and oral cavity in the US, 1998–2003. Cancer. 2008; 113: 2901–9.
   PubMed Web of Science ®Google Scholar
• Engberts MK, Vermeulen CF, Verbruggen BS, van Haaften M, Boon ME, Heintz AP. Candida and squamous (pre) neoplasia of immigrants and Dutch women as established in population-based cervical screening. Int J Gynecol Cancer. 2006; 16: 1596–600.
   Web of Science ®Google Scholar
• Firth NA, O'Grady JF, Reade PC. Oral squamous cell carcinoma in a young person with candidosis endocrinopathy syndrome: a case report. Int J Oral Maxillofac Surg. 1997; 26: 42–4.
   PubMed Web of Science ®Google Scholar
• Domingues-Ferreira M, Grumach AS, Duarte AJ, De Moraes-Vasconcelos D. Esophageal cancer associated with chronic mucocutaneous candidiasis. Could chronic candidiasis lead to esophageal cancer?. Med Mycol. 2009; 47: 201–5.
   PubMed Web of Science ®Google Scholar
• Rautemaa R, Hietanen J, Niissalo S, Pirinen S, Perheentupa J. Oral and oesophageal squamous cell carcinoma – a complication or component of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED, APS-I). Oral Oncol. 2007; 43: 607–13.
   PubMed Web of Science ®Google Scholar
• Rosa DD, Pasqualotto AC, Denning DW. Chronic mucocutaneous candidiasis and oesophageal cancer. Med Mycol. 2008; 46: 85–91.
   PubMed Web of Science ®Google Scholar
• D'Enfert C. Hidden killers: persistence of opportunistic fungal pathogens in the human host. Curr Opin Microbiol. 2009; 12: 358–64.
   PubMed Web of Science ®Google Scholar
• Bouza E, Muñoz P. Epidemiology of candidemia in intensive care units. Int J Antimicrob Agents. 2008; 32: S87–S91.
   PubMed Web of Science ®Google Scholar
• Marol S, Yücesoy M. Molecular epidemiology of Candida species isolated from clinical specimens of intensive care unit patients. Mycoses. 2008; 51: 40–9.
   Web of Science ®Google Scholar
• Cernea P, Crepy C, Kuffer R, Mascaro JM, Badillet G, Marie JL. Little known aspects of oral candidiasis. The candidiasis with multiple foci of the oral cavity. Rev Stomatol Chir Maxillofac. 1965; 66: 103–38.
   Google Scholar
• Jepsen A, Winther JE. Mycotic infection in oral leukoplakia. Acta Odontol Scand. 1965; 23: 239–56.
   PubMedGoogle Scholar
• Van der Waal I. Potentially malignant disorders of the oral and oropharyngeal mucosa: terminology, classification and present concepts of management. Oral Oncol. 2009; 45: 317–23.
   PubMed Web of Science ®Google Scholar
• Lipperheide V, Quindos G, Jimenez Y, Ponton J, Bagan-Sebastian JV, Aguirre JM. Candida biotypes in patients with oral leukoplakia and lichen planus. Mycopathologia. 1996; 134: 75–82.
   Web of Science ®Google Scholar
• Bartie KL, Williams DW, Wilson MJ, Potts AJ, Lewis MA. PCR fingerprinting of Candida albicans associated with chronic hyperplastic candidosis and other oral conditions. J Clin Microbiol. 2001; 39: 4066–75.
   PubMed Web of Science ®Google Scholar
• Krogh P, Holmstrup P, Thorn JJ, Vedtofte P, Pindborg JJ. Yeast species and biotypes associated with oral leukoplakia and lichen planus. Oral Surg Oral Med Oral Pathol. 1987; 63: 48–54.
   PubMedGoogle Scholar
• Cawson RA. Chronic oral candidiasis and leukoplakia. Oral Surg Oral Med Oral Pathol. 1966; 22: 582–91.
   PubMedGoogle Scholar
• Eyre J, Nally FF. Oral candidosis and carcinoma. Br J Dermatol. 1971; 85: 73–5.
   PubMed Web of Science ®Google Scholar
• Cawson RA, Lehner T. Chronic hyperplastic candidiasis – candidal leukoplakia. Br J Dermatol. 1968; 80: 9–16.
   PubMed Web of Science ®Google Scholar
• Lamey PJ, Lewis MA, MacDonald DG. Treatment of candidal leukoplakia with fluconazole. Br Dent J. 1989; 166: 296–8.
   PubMed Web of Science ®Google Scholar
• Samaranayake LP, MacFarlane TW. Oral candidosis. , London: Butterworth. 1990.
   Google Scholar
• Bartie KL, Williams DW, Wilson MJ, Potts AJ, Lewis MA. Differential invasion of Candida albicans isolates in an in vitro model of oral candidosis. Oral Microbiol Immunol. 2004; 19: 293–6.
   Google Scholar
• McCullough M, Jaber M, Barrett AW, Bain L, Speight PM, Porter SR. Oral yeast carriage correlates with presence of oral epithelial dysplasia. Oral Oncol. 2002; 38: 391–3.
   PubMed Web of Science ®Google Scholar
• Barret AW, Kinsmill VJ, Speight PM. The frequency of fungal infection in biopsies of oral mucosal lesions. Oral Diseases. 1998; 4: 26–31.
   Google Scholar
• Nagy KN, Sonkodi I, Szoke I, Nagy E, Newman HN. The microflora associated with human oral carcinomas. Oral Oncol. 1998; 34: 304–8.
   PubMed Web of Science ®Google Scholar
• de Repentigny L. Animal models in the analysis of Candida host–pathogen interactions. Curr Opin Microbiol. 2004; 7: 324–9.
   Web of Science ®Google Scholar
• Fidel PLJ. Immunity to Candida. Oral Dis. 2008; Suppl 2: 69–75.
   Google Scholar
• Cannon RD, Holmes AR, Mason AB, Monk BC. Oral Candida: clearance, colonization, or candidiasis?. J Dent Res. 1995; 74: 1152–61.
   PubMed Web of Science ®Google Scholar
• Cannon RD, Chaffin WL. Oral colonization by Candida albicans. Crit Rev Oral Biol Med. 1999; 10: 359–83.
   PubMedGoogle Scholar
• Filler SG, Sheppard DC. Fungal invasion of normally non-phagocytic host cells. PLoS Pathog. 2006; 2: e129.
   PubMed Web of Science ®Google Scholar
• Phan QT, Myers CL, Fu Y, Sheppard DC, Yeaman MR, Welch WH, et al.. Als3 is a Candida albicans invasin that binds to cadherins and induces endocytosis by host cells. PLoS Biol. 2007; 5: e64.
   PubMed Web of Science ®Google Scholar
• Dalle F, Wachtler B, L'Ollivier C, Holland G, Bannert N, Wilson D, et al.. Cellular interactions of Candida albicans with human oral epithelial cells and enterocytes. Cell Microbiol. 2010; 12: 248–71.
   PubMed Web of Science ®Google Scholar
• Critchley IA, Douglas LJ. Isolation and partial characterization of an adhesin from Candida albicans. J Gen Microbiol. 1987; 133: 629–36.
   PubMedGoogle Scholar
• Pietrella D, Lupo P, Rachini A, Sandini S, Ciervo A, Perito S, et al.. A Candida albicans mannoprotein deprived of its mannan moiety is efficiently taken up and processed by human dendritic cells and induces T-cell activation without stimulating proinflammatory cytokine production. Infect Immun. 2008; 76: 4359–67.
   PubMed Web of Science ®Google Scholar
• Mora-Montes HM, Ponce-Noyola P, Villagomez-Castro JC, Gow NA, Flores-Carreon A, Lopez-Romero E. Protein glycosylation in Candida. Future Microbiol. 2009; 4: 1167–83.
   PubMed Web of Science ®Google Scholar
• Li F, Palecek SP. Distinct domains of the Candida albicans adhesin Eap1p mediate cell–cell and cell–substrate interactions. Microbiol. 2008; 154: 1193–203.
   PubMed Web of Science ®Google Scholar
• Filler SJ. Candida–host cell receptor–ligand interactions. Curr Opin Microbiol. 2006; 9: 333–9.
   PubMed Web of Science ®Google Scholar
• Hooper SJ, Wilson MJ, Crean SJ. Exploring the link between microorganisms and oral cancer: a systemic review of the literature. Head Neck. 2009; 31: 1228–39.
   PubMed Web of Science ®Google Scholar
• Archer MC. Chemical carcinogenesis. The basic science of oncology. Tannock IF, Hill RPPergamon Press. New York, 1987; 89–105.
   Google Scholar
• Krogh P, Hald B, Holmstrup P. Possible mycological etiology of oral mucosal cancer: catalytic potential of infecting Candida albicans and other yeasts in production of N-nitrosobenzylmethylamine. Carcinogenesis. 1987; 8: 1543–8.
   PubMed Web of Science ®Google Scholar
• Dwivedi PP, Mallya S, Dongari-Bagtzoglou A. A novel immunocompetent murine model for Candida albicans-promoted oral epithelial dysplasia. Med Mycol. 2009; 47: 157–67.
   PubMed Web of Science ®Google Scholar
• O'Grady JF, Reade PC. Candida albicans as a promoter of oral mucosal neoplasia. Carcinogenesis. 1992; 13: 783–6.
   PubMed Web of Science ®Google Scholar
• Tuyns AJ. Alcohol and cancer. Proc Nutr Soc. 1990; 49: 145–51.
   Web of Science ®Google Scholar
• Zakhari S. Overview: how is alcohol metabolized by the body?. Alcohol Res Health. 2006; 29: 245–54.
   PubMedGoogle Scholar
• Seitz HK, Cho CH. Contribution of alcohol and tobacco use in gastrointestinal cancer development. Methods Mol Biol. 2009; 472: 217–41.
   PubMedGoogle Scholar
• Poschl G, Seitz HK. Alcohol and cancer. Alcohol. 2004; 39: 155–65.
   Web of Science ®Google Scholar
• Seitz HK, Stickel F. Molecular mechanisms of alcohol-mediated carcinogenesis. Nat Rev Cancer. 2007; 7: 599–612.
   PubMed Web of Science ®Google Scholar
• Homann N, Tillonen J, Meurman JH, Rintamaki H, Lindqvist C, Rautio M, et al.. Increased salivary acetaldehyde levels in heavy drinkers and smokers: a microbiological approach to oral cavity cancer. Carcinogenesis. 2000; 21: 663–8.
   PubMed Web of Science ®Google Scholar
• Kurkivuori J, Salaspuro V, Kaihovaara P, Kari K, Rautemaa R, Grönroos L, et al.. Acetaldehyde production from ethanol by oral streptococci. Oral Oncol. 2007; 43: 181–6.
   PubMed Web of Science ®Google Scholar
• Salaspuro MP. Acetaldehyde, microbes, and cancer of the digestive tract. Crit Rev Clin Lab Sci. 2003; 40: 183–208.
   PubMed Web of Science ®Google Scholar
• Vakevainen S, Mentula S, Nuutinen H, Salmela KS, Jousimies-Somer H, Färkkilä M, et al.. Ethanol derived microbial production of carcinogenic acetaldehyde in achlorhydric atrophic gastritis. Scand J Gastroenterol. 2002; 37: 648–55.
   PubMed Web of Science ®Google Scholar
• Collings A, Holmes AR, Shepherd MG. Secretion of end-products of metabolism by Candida species. Biomed Lett. 1991; 46: 285–96.
   Google Scholar
• Davidson BJ, Hsu TC, Schantz SP. The genetics of tobacco-induced malignancy. Arch Otolaryngol Head Neck Surg. 1993; 119: 1198–205.
   PubMedGoogle Scholar
• Salaspuro VJ, Hietala JM, Marvola ML, Salaspuro MP. Eliminating carcinogenic acetaldehyde by cysteine from saliva during smoking. Cancer Epidemiol Biomarkers Prev. 2006; 15: 146–9.
   PubMed Web of Science ®Google Scholar
• Meurman JH.. Oral microbiota and cancer. J Oral Microbiol. 2010; 2: 5195. 10.3402/jom.v2i0.5780.
   Google Scholar
• Nakamura T, Matsumoto K, Kiritoshi A, Tano Y. Induction of hepatocyte growth factor in fibroblasts by tumor-derived factors affects invasive growth of tumor cells: in vitro analysis of tumor-stromal interactions. Cancer Res. 1997; 57: 3305–13.
   PubMed Web of Science ®Google Scholar
• Schreurs J. Cytokines in infectious disease: the battle between host and pathogen. Curr Opin Biotechnol. 1993; 4: 727–33.
   Google Scholar
• Rich AM, Reade PC. Epithelial-mesenchymal interactions in experimental oral mucosal carcinogenesis. J Oral Pathol Med. 2001; 30: 389–97.
   Web of Science ®Google Scholar
• Natarajan E, Saeb M, Crum CP, Woo SB, McKee PH, Rheinwald JG. Co-expression of p16(INK4A) and laminin 5 gamma2 by microinvasive and superficial squamous cell carcinomas in vivo and by migrating wound and senescent keratinocytes in culture. Am J Pathol. 2003; 163: 477–91.
   PubMed Web of Science ®Google Scholar
• Wandall HH, Dabelsteen S, Sorensen JA, Krogdahl A, Mandel U, Dabelsteen E. Molecular basis for the presence of glycosylated onco-foetal fibronectin in oral carcinomas: the production of glycosylated onco-foetal fibronectin by carcinoma cells. Oral Oncol. 2007; 43: 301–9.
   Web of Science ®Google Scholar
• Morschhäuser J, Virkola R, Korhonen TK, Hacker J. Degradation of human subendothelial extracellular matrix by proteinase-secreting Candida albicans. FEMS Microbiol Lett. 1997; 153: 349–55.
   Web of Science ®Google Scholar
• Rodier M-H, El Moudni B, Kauffmann-Lacroix C, Daniault G, Jacquemin J-L. A Candida albicans metallopeptidase degrades constitutive proteins of extracellular matrix. FEMS Microbiol Lett. 1999; 177: 205–10.
   PubMed Web of Science ®Google Scholar
• Pärnänen P, Kari K, Virtanen I, Sorsa T, Meurman JH. Human laminin-332 degradation by Candida proteinases. J Oral Pathol Med. 2008; 37: 329–35.
   Web of Science ®Google Scholar
• Pärnänen P, Meurman JH, Samaranayake L, Virtanen I. Human oral keratinocyte E-cadherin degradation by Candida albicans and Candida glabrata. J Oral Pathol Med. 2010; 39: 275–8.
   PubMed Web of Science ®Google Scholar
• Fantini MC, Pallone F. Cytokines: from gut inflammation to colorectal cancer. Curr Drug Targets. 2008; 9: 375–80.
   PubMed Web of Science ®Google Scholar
• Lax AJ, Thomas W. How bacteria could cause cancer: one step at a time. Trends Microbiol. 2002; 10: 293–9.
   PubMed Web of Science ®Google Scholar
• Sun WH, Yu Q, Shen H, Ou XL, Cao DZ, Yu T, et al.. Roles of Helicobacter pylori infection and cyclooxygenase-2 expression in gastric carcinogenesis. World J Gastroenterol. 2004; 10: 2809–13.
   PubMed Web of Science ®Google Scholar
• Thun MJ, Namboodiri MM, Calle EE, Flanders WD, Health CW Jr. Aspirin use and the risk of fatal cancer. Cancer Res. 1993; 53: 1322–7.
   PubMed Web of Science ®Google Scholar
• Zhao Y, Hao Y, Ji H, Fang Y, Guo Y, Sha W, et al.. Combination effects of salvianolic acid B with low-dose celecoxib on inhibition of head and neck squamous cell carcinoma growth in vitro and in vivo. Cancer Prev Res. 2010; 3: 787–96.
   PubMed Web of Science ®Google Scholar
• Cha J-D, Li S, Cha I-H. Association between expression of embryonic lethal abnormal vision-like protein HuR and cyclooxygenase-2 in oral squamous cell carcinoma. Head Neck. 2010. 10.3402/jom.v2i0.5780.
   Google Scholar
• Orozco AS, Zhou X, Filler SG. Mechanisms of the proinflammatory response of endothelial cells to Candida albicans infection. Infect Immun. 2000; 68: 1134–41.
   PubMed Web of Science ®Google Scholar
• Wenghoefer M, Pantelis A, Najafi T, Deschner J, Allam JP, Novak N, et al.. Gene expression of oncogenes, antimicrobial peptides, and cytokines in the development of oral leukoplakia. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2010; 110: 351–6.
   PubMed Web of Science ®Google Scholar
• Gale N, Pilch BZ, Sidransky D, El Haggar A, Westra W, Califano J, et al.Epithelial precursor lesions. World Health Organization classification of tumours. Pathology and genetics of head and neck tumours. Barnes L, Eveson JW, Reichart P, Sidransky DIARC Press. Lyon, 2005; 177.
   Google Scholar
• Mantovani A, Allavena P, Sica A, Balkwill F. Cancer-related inflammation. Nature. 2008; 454: 436–44.
   PubMed Web of Science ®Google Scholar
• Karin M. Nuclear factor κB in cancer development and progression. Nature. 2006; 441: 431–6.
   PubMed Web of Science ®Google Scholar
• Netea MG, Sutmuller R, Hermann C, Van der Graf CAA, Van der Meer JWM, Adema G, et al.. Toll-like receptor 2 inhibits cellular responses against Candida albicans through pathways mediated by IL-10 and CD4 + CD25+ regulatory T cells. J Immunol. 2004; 172: 3712–8.
   PubMed Web of Science ®Google Scholar
• Rodriguez-Cuesta J, Hernando FL, Mendoza L, Gallot N, de Cerio AA, Martinez-de-Tejada G, et al.. Candida albicans enhances experimental hepatic melanoma metastasis. Clin Exp Metastasis. 2010; 27: 35–42.
   PubMed Web of Science ®Google Scholar
• Sitheeque MAM, Samaranayake LP. Chronic hyperplastic candidosis/candidiasis (candidal leukoplakia). Crit Rev Oral Biol Med. 2003; 14: 253–67.
   PubMedGoogle Scholar